Search

Your search keyword '"Pérez Torre, Paula"' showing total 15 results
Start Over Author "Pérez Torre, Paula"
15 results on '"Pérez Torre, Paula"'

3. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study

Author

Alonso-Canovas, Araceli, Tembl Ferrairó, José Ignacio, Martínez-Torres, Irene, Lopez-Sendon Moreno, Jose Luis, Parees-Moreno, Isabel, Monreal-Laguillo, Enric, Pérez-Torre, Paula, Toledano Delgado, Rafael, García Ribas, Guillermo, Sastre Bataller, Isabel, Masjuan, Jaime, Martinez-Castrillo, Juan Carlos, and Walter, Uwe

Published
2019
Full Text
View/download PDF

4. ¿Qué piensan los estudiantes de Medicina sobre los trastornos neurológicos funcionales?

Author

Escribano Paredes, José Bernardo, primary, Natera Villalba, Elena, additional, Porta Etessam, Jesús, additional, Vela Desojo, Lydia, additional, García Ruiz-Espiga, Pedro José, additional, Alonso Cánovas, Araceli, additional, López-Sendón Moreno, José Luis, additional, Pérez Torre, Paula, additional, Fanjul Arbós, Samira, additional, Lledó, Lourdes, additional, Martínez Castrillo, Juan Carlos, additional, and Pareés Moreno, Isabel, additional

Published
2023
Full Text
View/download PDF

5. Efficacy and safety of high doses of safinamide in advanced Parkinson disease

Author

Rodríguez-Jorge, Fernando, primary, Beltrán-Corbellini, Álvaro, additional, Chico-García, J.L., additional, Parra-Díaz, Paloma, additional, Baena-Álvarez, Belén, additional, Pagonabarraga, Javier, additional, Pérez-Torre, Paula, additional, Pareés, Isabel, additional, López-Sendón, J.L., additional, Martínez-Castrillo, J.C., additional, and Alonso-Cánovas, Araceli, additional

Published
2022
Full Text
View/download PDF

7. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19.

Author

Monreal, Enric, primary, Maza, Susana Sainz de la, additional, Gullón, Pedro, additional, Natera-Villalba, Elena, additional, Chico-García, Juan Luis, additional, Beltrán-Corbellini, Álvaro, additional, Martínez-Sanz, Javier, additional, García-Barragán, Nuria, additional, Buisán, Javier, additional, Toledano, Rafael, additional, Alonso-Canovas, Araceli, additional, Pérez-Torre, Paula, additional, Matute-Lozano, María Consuelo, additional, López-Sendón, Jose Luis, additional, García-Ribas, Guillermo, additional, Corral, Íñigo, additional, Fortún, Jesús, additional, Montero-Errasquín, Beatriz, additional, Manzano, Luis, additional, Máiz-Carro, Luis, additional, Costa-Frossard, Lucienne, additional, and Masjuan, Jaime, additional

Published
2020
Full Text
View/download PDF

8. Immunosuppression is associated with a lower risk of moderate to severe acute respiratory distress syndrome in COVID-19.

Author

Monreal, Enric, primary, Maza, Susana Sainz de la, additional, Gullón, Pedro, additional, Natera-Villalba, Elena, additional, Chico-García, Juan Luis, additional, Beltrán-Corbellini, Álvaro, additional, Martínez-Sanz, Javier, additional, García-Barragán, Nuria, additional, Buisán, Javier, additional, Toledano, Rafael, additional, Alonso-Canovas, Araceli, additional, Pérez-Torre, Paula, additional, Matute-Lozano, María Consuelo, additional, López-Sendón, Jose Luis, additional, García-Ribas, Guillermo, additional, Corral, Íñigo, additional, Fortún, Jesús, additional, Montero-Errasquín, Beatriz, additional, Manzano, Luis, additional, Máiz-Carro, Luis, additional, Costa-Frossard, Lucienne, additional, and Masjuan, Jaime, additional

Published
2020
Full Text
View/download PDF

9. Non‐severe immunosuppression might be associated with a lower risk of moderate–severe acute respiratory distress syndrome in COVID‐19: A pilot study.

Author

Monreal, Enric, Maza S, Sainz de la, Gullón, Pedro, Natera‐Villalba, Elena, Chico‐García, Juan Luis, Beltrán‐Corbellini, Álvaro, Martínez‐Sanz, Javier, García‐Barragán, Nuria, Buisán, Javier, Toledano, Rafael, Alonso‐Canovas, Araceli, Pérez‐Torre, Paula, Matute‐Lozano, María C., López‐Sendón, Jose Luis, García‐Ribas, Guillermo, Corral, Íñigo, Fortún, Jesús, Montero‐Errasquín, Beatriz, Manzano, Luis, and Máiz‐Carro, Luis

Subjects
ADULT respiratory distress syndrome, COVID-19, IMMUNOSUPPRESSION, TSUTSUGAMUSHI disease
Abstract

The role of immunosuppression among coronavirus disease 2019 (COVID‐19) patients has not been elucidated and management may be challenging. This observational study included confirmed COVID‐19 patients. The primary endpoint was the development of moderate–severe acute respiratory distress syndrome (ARDS). Time to moderate–severe ARDS, the need for mechanical or noninvasive ventilation (MV/NIV), death, and a composite of death or MV/NIV were secondary endpoints. Of 138 patients included, 27 (19.6%) were immunosuppressed (IS) and 95 (68.8%) were male, with a median (IQR) age of 68 (54–78) years. A significantly lower proportion of IS patients (25.9%) compared to non‐IS patients (52.3%) developed moderate–severe ARDS, in both unadjusted (0.32; 95% CI, 0.13–0.83; p =.017) and adjusted (aOR, 0.25; 95% CI, 0.08–0.80; p =.019) analyses. After stratifying by pathologies, only IS patients with autoimmune diseases remained significant (aOR 0.25; 95% CI, 0.07–0.98; p =.046). Nonsignificant trends toward a longer time to moderate or severe ARDS, a lower need for MV/NIV, and a lower risk of death or MV/NIV were detected among IS. In our cohort of COVID‐19 patients, nonsevere immunosuppression was associated with a lower risk of moderate–severe ARDS, especially among AD. This suggests a potential protective effect from a hypothesized hyper‐inflammatory response. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

10. Dimensiones de la aurícula izquierda en pacientes con ictus isquémico criptogénico como método para predecir el desarrollo de fibrilación auricular.

Author

Cruz Culebras, Antonio, Pérez Torre, Paula, Vera, Rocío, Pascual Izco, Marina, Cruz Culebras, Antonio, Pérez Torre, Paula, Vera, Rocío, and Pascual Izco, Marina

Abstract

Objective: To determine whether the left atrial size can predict the development of atrial fibrillation (AF) in patients with embolic stroke of undetermined source (ESUS).Methods: Patients with ischemic stroke were included prospectively (January 2015-July 2015) when ESUS was suspected. Clinical and cardiac imaging data were recorded. Patients with cardiac failure were excluded.Results: a total of 55 patients were included. Medium age was 71 years. The proportion of patients who developed AF during the follow-up (1 year) was 23, 63%. 10 % of patients did not have any vascular risk factor. Basal ECG was normal in 98% of cases. The left atrial size volume was 36, 08 ml in patients who developed AF and 27, 14 ml in patients who did not.Conclusions: In patients with ESUS, left atrial size dimensions do not predict the occurrence of AF., Objetivos. Determinar si el grado de dilatación de aurícula izquierda (AI) nos permitirían predecir la existencia de fibrilación auricular (FA) subyacente en pacientes con ictus embólico de origen indeterminado.Material y métodos. Se incluyeron de manera prospectiva pacientes que acudieron como Código Ictus a nuestro centro (Enero 2015-Julio 2015), con sospecha etiológica de embolia sin arritmia documentada. Se documentaron datos clínicos y de imagen cardíaca.Resultados. Un total de 55 pacientes fueron incluidos en el estudio. La edad media fue de 71 años. El porcentaje de pacientes que desarrollaron FA durante el seguimiento (1 año) fue del 23,63%. Un 10% de los pacientes no presentaban ningún factor de riesgovascular clásico. El ECG basal fue normal en el 98%. El volumen medio de AI en ETT ajustado por superficie corporal fue de 36,08 ml en pacientes que desarrollaron FA y de 27,14 ml en aquellos que no la desarrollaron.Conclusiones. En pacientes con ictus isquémico con sospecha mecanismo embólico las dimensiones de la aurícula izquierda no predicen el desarrollo de FA a medio plazo

Published
2017

13. Acute myelitis by human herpes virus 7 in an HIV-infected patient

Author

Escobar-Villalba, Alfonso, primary, Sainz de la Maza, Susana, additional, Pérez Torre, Paula, additional, Galán, Juan Carlos, additional, Rodríguez-Domínguez, Mario, additional, Monreal Laguillo, Enric, additional, Martínez Ulloa, Pedro Luis, additional, Buisán Catevilla, Javier, additional, and Corral, Iñigo, additional

Published
2016
Full Text
View/download PDF

14. Utilización de haloperidol en un paciente con síndrome de encefalomiopatía mitocondrial, acidosis láctica y episodios parecidos a ictus (síndrome MELAS)

Author

Acebrón Sánchez-Herrera, Fernando, primary, Anciones Martín, Carla, additional, de Albóniga-Chindurza Barroeta, Asier, additional, Guirao Rubio, Carlos Miguel, additional, Pérez Torre, Paula, additional, Vives Luengo, Alicia, additional, Corral Corral, Iñigo, additional, Alonso Cánovas, Araceli, additional, and Ortiz Rodríguez, Javier, additional

Published
2015
Full Text
View/download PDF

15. PLA2G6 -Associated Neurodegeneration: Report of a Novel Mutation in Two Siblings with Strikingly Different Clinical Presentation.

Author

Pérez‐Torre, Paula, Escobar Villalba, Alfonso, Martínez Ulloa, Pedro, Kawiorski, Michal, Jiménez‐Escrig, Adriano, Bazán, Eulalia, Gonzalo‐Gobernado, Rafael, and Herranz, Antonio S.

Subjects
*NEURODEGENERATION, *EXTRAPYRAMIDAL disorders, *CENTRAL nervous system diseases, *MOVEMENT disorders, *IRON in the body
Abstract

View Supplementary Video View Supplementary Video [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results